A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers.

Clinical trial NCT02238782 · COMPLETED

Trial details

NCT number: NCT02238782
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Bioavailability Study

Start date: 2014-10-01
Primary completion: 2014-11-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.